SlideShare una empresa de Scribd logo
1 de 9
Descargar para leer sin conexión
Emerging Biopharmaceutical Markets to Witness Exponential
Growth

IMARC Group, one of the world‘s leading research and advisory firms, finds that the sales of
Biopharmaceuticals in Emerging markets will nearly triple its size from US$ 5.3 Billion in 2010 to
US$ 13.5 Billion in 2015



IMARC Group, one of the world‘s leading research and advisory firms, finds in its new report
“Global Biopharmaceutical Market Report & Forecast 2010-2015” that driven by a huge patient pool,
rapid economic growth and improving intellectual property rights, the sales of biopharmaceuticals in the seven
emerging markets - Russia, China, Turkey, Mexico, South Korea, India and Brazil will nearly triple from the
current       US$     5.3     Billion    to      more      than      US$        13.6    billion    by       2015.


As per the research findings, the treatment costs associated with biopharmaceuticals are extremely high and at
times can exceed hundreds of thousands of dollars a year. Since most of the healthcare costs in the emerging
markets are paid out-of-pocket, most patients cannot afford these treatments. However, the seven emerging
markets taken together account for more than three billion people, representing more than 45% of the total
Global population. So even if a small percentage of patients are able to afford these drugs, it still represents a
huge market potential. Moreover, the GDPs of emerging markets have witnessed strong growth during the last
few years, and this is likely to continue in the coming years as well. This is expected to create a huge middle
class that can afford innovative treatments.




The report also suggests that despite the huge opportunity, these markets will not be easy for western
manufacturers to penetrate. A major challenge for manufacturers entering these markets is the fact that
emerging markets are more complex and different from the developed markets as well as from each other. A
strategy that will work in Turkey will not work well in India or China. Manufacturers will have to devise
strategies,     customized      as      per     the     requirements       of     the     individual      markets.


IMARC’s new report “Global Biopharmaceutical Market Report 2010-2015” gives a deep insight into the
global biopharmaceutical market. The research study serves as an analytical as well as a statistical tool to
understand the strengths, weaknesses, opportunities, threats, market trends, geographical structure,
therapeutic structure, competitive structure and the outlook of the global biopharmaceutical market till 2015.
This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists, and
all those who are planning to foray into the global biopharmaceutical market in some form or the other.
Report Highlights:


       Biopharmaceuticals enjoy a higher approval success rate compared to traditional small molecule
        drugs. They, however, require higher investments and take longer development times.


       Biopharmaceuticals are significantly more expensive than traditional medications, with the annual cost
        of therapy of some biopharmaceuticals touching more than a hundred thousand dollars a year. The
        cost of these drugs, however, is expected to be closely scrutinized by payers in the coming years.
       Recombinant Proteins represented the biggest biopharmaceutical class in 2009, accounting for more
        than 65% of the total global biopharmaceutical sales. Growth in this class is expected to be low in most
        of the developed markets as a result of biosimilar entry and increasing cost containment measures.


       Monoclonal Antibodies are expected to be the biggest drivers of the biopharmaceutical market in the
        next five years. Driven by a rich late stage pipeline and a strong uptake from both developed and
        emerging market, Monoclonal Antibodies are expected to be worth more than US$ 79 Billion by 2015.


       Imarc expects the top eight markets (US, Germany, Japan, France, Italy, Spain, UK and Canada) to
        account for around 79% of the total global biopharmaceutical sales by 2015. This represents a decline
        of 4% over their 2009 share.


       The market share of emerging markets (Brazil, Russia, India, China, Mexico, Turkey and South Korea)
        is likely to increase from less than 5% in 2009 to more than 8% by 2015.


Countries Covered
Global, US, Germany, Japan, France, Italy, Spain, United Kingdom, Canada, Russia, China, Australia, Turkey,
Mexico, South Korea, India, Brazil, Argentina and Indonesia.


Classes Covered for Each Region/Country
Recombinant Proteins, Insulin, Erythropoietins, Interferons, Colony Stimulating Factors, Immunoglobulins,
Recombinant Blood Factors, Growth Hormones, Recombinant Enzymes, Interleukins, Growth Factors,
Monoclonal Antibodies and Purified Proteins.


Key Features
       Analysis of the key strengths, weaknesses, opportunities and threats faced by the global
        biopharmaceutical market.
       Exhaustive in-depth individual analysis for eighteen major developed and emerging markets.
       2005 to 2009 trend analysis for the global and 18 selected biopharmaceutical markets.
   2005 to 2009 trend analysis for individual biopharmaceutical classes for the global and 18 selected
    biopharmaceutical markets.
   2005 to 2009 trend analysis for the performance of top players for the global and 18 selected
    biopharmaceutical markets.


Table of Contents


1. Market Definitions & Research Methodology
2. Analyst Briefing
3. Introduction to Biopharmaceuticals
4. Global Biopharmaceutical Market: Industry Analysis
4.1 Strengths
4.1.1 High Efficacy and Target Oriented Attack
4.1.2 Strong Potential to Achieve Blockbuster Status
4.1.3 Limited Generic Threat
4.1.4 Approval Success Rates are Higher than Small Molecule Drugs
4.2 Weaknesses
4.2.1 Inconvenient Drug Delivery Coupled with Short Half Lives
4.2.2 Second Line of Therapy
4.2.3 Huge Cost of Therapy
4.2.4 High Incidence of Unfavorable Side Effects
4.3 Opportunities
4.3.1 Diseases with High Unmet Needs
4.3.2 Expanding the Patient Pool by Approval into Additional Indications
4.3.3 Emerging Markets
4.3.4 Increasing New Approvals and a Strong Pipeline
4.4 Threats
4.4.1 Biopharmaceutical Drug Development is a Very Risky Venture
4.4.2 Biosimilars
4.4.3 Limited and Conditional Reimbursement
4.4.4 Uncertainties in the Economic Environment
5. Global Biopharmaceutical Market: Industry Performance
5.1 Market Performance & Forecast
5.1.1 Current Performance (2005-2009)
5.1.2 Market Forecasts (2010-2015)
5.2 Market Segmentation by Region
5.2.1 Current Performance (2005-2009)
5.2.2 Market Forecasts (2010-2015)
5.3 Market Segmentation by Indication
5.4 Market Segmentation by Class
5.4.1 Recombinant Proteins
5.4.2 Monoclonal Antibodies
5.4.3 Purified Proteins
5.5 Competitive Landscape
5.5.1 Top Biopharmaceutical Players
5.5.2 Top Biopharmaceutical Drugs
6. North America
6.1 US
6.1.1 Market Performance (2005-2009)
6.1.2 Market Segmentation by Class
6.1.3 Performance of Top Players
6.1.4 Market Forecasts (2010-2015)
6.2 Canada
6.2.1 Market Performance (2005-2009)
6.2.2 Market Segmentation by Class
6.2.3 Performance of Top Players
6.2.4 Market Forecasts (2010-2015)
7. Latin America
7.1 Mexico
7.1.1 Market Performance (2005-2009)
7.1.2 Market Segmentation by Class
7.1.3 Performance of Top Players
7.1.4 Market Forecasts (2010-2015)
7.2 Brazil
7.2.1 Market Performance (2005-2009)
7.2.2 Market Segmentation by Class
7.2.3 Performance of Top Players
7.2.4 Market Forecasts (2010-2015)
7.3 Argentina
7.3.1 Market Performance (2005-2009)
7.3.2 Market Segmentation by Class
7.3.3 Performance of Top Players
7.3.4 Market Forecasts (2010-2015)
8. Europe
8.1 Germany
8.1.1 Market Performance (2005-2009)
8.1.2 Market Segmentation by Class
8.1.3 Performance of Top Players
8.1.4 Market Forecasts (2010-2015)
8.2 France
8.2.1 Market Performance (2005-2009)
8.2.2 Market Segmentation by Class
8.2.3 Performance of Top Players
8.2.4 Market Forecasts (2010-2015)
8.3 Italy
8.3.1 Market Performance (2005-2009)
8.3.2 Market Segmentation by Class
8.3.3 Performance of Top Players
8.3.4 Market Forecasts (2010-2015)
8.4 Spain
8.4.1 Market Performance (2005-2009)
8.4.2 Market Segmentation by Class
8.4.3 Performance of Top Players
8.4.4 Market Forecasts (2010-2015)
8.5 UK
8.5.1 Market Performance (2005-2009)
8.5.2 Market Segmentation by Class
8.5.3 Performance of Top Players
8.5.4 Market Forecasts (2010-2015)
8.6 Russia
8.6.1 Market Performance (2005-2009)
8.6.2 Market Segmentation by Class
8.6.3 Performance of Top Players
8.6.4 Market Forecasts (2010-2015)
8.7 Turkey
8.7.1 Market Performance (2005-2009)
8.7.2 Market Segmentation by Class
8.7.3 Performance of Top Players
8.7.4 Market Forecasts (2010-2015)
9. Asia Pacific
9.1 Japan
9.1.1 Market Performance (2005-2009)
9.1.2 Market Segmentation by Class
9.1.3 Performance of Top Players
9.1.4 Market Forecasts (2010-2015)
9.2 China
9.2.1 Market Performance (2005-2009)
9.2.2 Market Segmentation by Class
9.2.3 Performance of Top Players
9.2.4 Market Forecasts (2010-2015)
9.3 Australia
9.3.1 Market Performance (2005-2009)
   9.3.2 Market Segmentation by Class
   9.3.3 Performance of Top Players
   9.3.4 Market Forecasts (2010-2015)
   9.4 South Korea
   9.4.1 Market Performance (2005-2009)
   9.4.2 Market Segmentation by Class
   9.4.3 Performance of Top Players
   9.4.4 Market Forecasts (2010-2015)
   9.5 India
   9.5.1 Market Performance (2005-2009)
   9.5.2 Market Segmentation by Class11
   9.5.3 Performance of Top Players
   9.5.4 Market Forecasts (2010-2015)
   9.6 Indonesia
   9.6.1 Market Performance (2005-2009)
   9.6.2 Market Segmentation by Class
   9.6.3 Performance of Top Players
   9.6.4 Market Forecasts (2010-2015)


   To buy the complete report or to get a free sample, please contact:

IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-425-6531

IMARC Group North America
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331

To know more please visit: http://www.imarcgroup.com/global-biopharmaceutical-market-report-
2010-2015/
Keywords


Biopharmaceuticals market, Global Biopharmaceuticals market, Pharmaceuticals market, Recombinant proteins
market, Monoclonal anti-bodies market, Purified Proteins market
   2010-2015 sales forecast for the global and 18 selected biopharmaceutical markets.

Más contenido relacionado

La actualidad más candente

Cancer immunotherapies from the perspectives of oncology nurses
Cancer immunotherapies from the perspectives of oncology nursesCancer immunotherapies from the perspectives of oncology nurses
Cancer immunotherapies from the perspectives of oncology nursesZeena Nackerdien
 
The Current Oncology Pipeline: Development & Launch
The Current Oncology Pipeline: Development & LaunchThe Current Oncology Pipeline: Development & Launch
The Current Oncology Pipeline: Development & LaunchHannah Law
 
Presentation Assogenerici_Biosimilars_Iervolino IMS
Presentation Assogenerici_Biosimilars_Iervolino IMSPresentation Assogenerici_Biosimilars_Iervolino IMS
Presentation Assogenerici_Biosimilars_Iervolino IMSAntonio Iervolino
 
Download Global biosimilars market & pipeline insight 2018
Download Global biosimilars market & pipeline insight 2018Download Global biosimilars market & pipeline insight 2018
Download Global biosimilars market & pipeline insight 2018KuicK Research
 
Growth of Nanomedicine Market in a new 2016 report
Growth of Nanomedicine Market in a new 2016 reportGrowth of Nanomedicine Market in a new 2016 report
Growth of Nanomedicine Market in a new 2016 reportPete Jones
 
2014 Profile: Biopharmaceutical Research Industry
2014 Profile: Biopharmaceutical Research Industry2014 Profile: Biopharmaceutical Research Industry
2014 Profile: Biopharmaceutical Research IndustryPhRMA
 
WMStrategy Demo The Global Isopropanol Market June 2019
WMStrategy Demo The Global Isopropanol Market June 2019WMStrategy Demo The Global Isopropanol Market June 2019
WMStrategy Demo The Global Isopropanol Market June 2019Williams & Marshall Strategy
 
Aminoglycosides Market Analysis By Drug, Mode of Administration, Application...
 Aminoglycosides Market Analysis By Drug, Mode of Administration, Application... Aminoglycosides Market Analysis By Drug, Mode of Administration, Application...
Aminoglycosides Market Analysis By Drug, Mode of Administration, Application...Grand View Research
 
Mera medicare ppt
Mera medicare pptMera medicare ppt
Mera medicare pptRohit Kumar
 
Chemotherapy Market Size, Share & Forecast | TechSci Research
Chemotherapy Market Size, Share & Forecast | TechSci Research Chemotherapy Market Size, Share & Forecast | TechSci Research
Chemotherapy Market Size, Share & Forecast | TechSci Research TechSci Research
 
BSE IMP project report
BSE IMP project reportBSE IMP project report
BSE IMP project reportshub09
 
GDHC118PIDR_Peripheral Artery Disease_sample
GDHC118PIDR_Peripheral Artery Disease_sampleGDHC118PIDR_Peripheral Artery Disease_sample
GDHC118PIDR_Peripheral Artery Disease_sampleShaan Thakerar
 
Global vitamin ingredient market
Global vitamin ingredient marketGlobal vitamin ingredient market
Global vitamin ingredient marketneha pundhir
 
Biological Safety Testing Market Size, Product Analysis and Applications, 201...
Biological Safety Testing Market Size, Product Analysis and Applications, 201...Biological Safety Testing Market Size, Product Analysis and Applications, 201...
Biological Safety Testing Market Size, Product Analysis and Applications, 201...Signitech
 
The us pharmaceutical industry outlook to 2016 sample report
The us pharmaceutical industry outlook to 2016 sample reportThe us pharmaceutical industry outlook to 2016 sample report
The us pharmaceutical industry outlook to 2016 sample reportAMMindpower
 
Global market size in drug lead and precursor
Global market size in drug lead and precursorGlobal market size in drug lead and precursor
Global market size in drug lead and precursorPriya Saraf
 

La actualidad más candente (20)

2016-EDF-Pharma-Innovation
2016-EDF-Pharma-Innovation2016-EDF-Pharma-Innovation
2016-EDF-Pharma-Innovation
 
Cancer immunotherapies from the perspectives of oncology nurses
Cancer immunotherapies from the perspectives of oncology nursesCancer immunotherapies from the perspectives of oncology nurses
Cancer immunotherapies from the perspectives of oncology nurses
 
The Current Oncology Pipeline: Development & Launch
The Current Oncology Pipeline: Development & LaunchThe Current Oncology Pipeline: Development & Launch
The Current Oncology Pipeline: Development & Launch
 
Presentation Assogenerici_Biosimilars_Iervolino IMS
Presentation Assogenerici_Biosimilars_Iervolino IMSPresentation Assogenerici_Biosimilars_Iervolino IMS
Presentation Assogenerici_Biosimilars_Iervolino IMS
 
Pharma Industry
Pharma IndustryPharma Industry
Pharma Industry
 
Download Global biosimilars market & pipeline insight 2018
Download Global biosimilars market & pipeline insight 2018Download Global biosimilars market & pipeline insight 2018
Download Global biosimilars market & pipeline insight 2018
 
Growth of Nanomedicine Market in a new 2016 report
Growth of Nanomedicine Market in a new 2016 reportGrowth of Nanomedicine Market in a new 2016 report
Growth of Nanomedicine Market in a new 2016 report
 
2014 Profile: Biopharmaceutical Research Industry
2014 Profile: Biopharmaceutical Research Industry2014 Profile: Biopharmaceutical Research Industry
2014 Profile: Biopharmaceutical Research Industry
 
WMStrategy Demo The Global Isopropanol Market June 2019
WMStrategy Demo The Global Isopropanol Market June 2019WMStrategy Demo The Global Isopropanol Market June 2019
WMStrategy Demo The Global Isopropanol Market June 2019
 
Aminoglycosides Market Analysis By Drug, Mode of Administration, Application...
 Aminoglycosides Market Analysis By Drug, Mode of Administration, Application... Aminoglycosides Market Analysis By Drug, Mode of Administration, Application...
Aminoglycosides Market Analysis By Drug, Mode of Administration, Application...
 
Global non
Global nonGlobal non
Global non
 
Mera medicare ppt
Mera medicare pptMera medicare ppt
Mera medicare ppt
 
Chemotherapy Market Size, Share & Forecast | TechSci Research
Chemotherapy Market Size, Share & Forecast | TechSci Research Chemotherapy Market Size, Share & Forecast | TechSci Research
Chemotherapy Market Size, Share & Forecast | TechSci Research
 
BSE IMP project report
BSE IMP project reportBSE IMP project report
BSE IMP project report
 
GDHC118PIDR_Peripheral Artery Disease_sample
GDHC118PIDR_Peripheral Artery Disease_sampleGDHC118PIDR_Peripheral Artery Disease_sample
GDHC118PIDR_Peripheral Artery Disease_sample
 
Global vitamin ingredient market
Global vitamin ingredient marketGlobal vitamin ingredient market
Global vitamin ingredient market
 
Biological Safety Testing Market Size, Product Analysis and Applications, 201...
Biological Safety Testing Market Size, Product Analysis and Applications, 201...Biological Safety Testing Market Size, Product Analysis and Applications, 201...
Biological Safety Testing Market Size, Product Analysis and Applications, 201...
 
The us pharmaceutical industry outlook to 2016 sample report
The us pharmaceutical industry outlook to 2016 sample reportThe us pharmaceutical industry outlook to 2016 sample report
The us pharmaceutical industry outlook to 2016 sample report
 
Global market size in drug lead and precursor
Global market size in drug lead and precursorGlobal market size in drug lead and precursor
Global market size in drug lead and precursor
 
Proteomics ppt
Proteomics pptProteomics ppt
Proteomics ppt
 

Similar a Emerging Biopharmaceutical Markets to Witness Exponential Growth

Biosurfactants market
Biosurfactants marketBiosurfactants market
Biosurfactants marketameliasimon0
 
Biologics market
Biologics market Biologics market
Biologics market stephenb65
 
Biosimilars/Follow-on-Biologics Market
Biosimilars/Follow-on-Biologics Market Biosimilars/Follow-on-Biologics Market
Biosimilars/Follow-on-Biologics Market Lilly Floyd
 
M&A in pharmaceutical industry between india and italy
M&A in pharmaceutical industry between india and italyM&A in pharmaceutical industry between india and italy
M&A in pharmaceutical industry between india and italyVishal Singh
 
Multiple myeloma therapeutics in major developed markets to 2021 growth dri...
Multiple myeloma therapeutics in major developed markets to 2021   growth dri...Multiple myeloma therapeutics in major developed markets to 2021   growth dri...
Multiple myeloma therapeutics in major developed markets to 2021 growth dri...David2591
 
Nanomedicine Market Size 2013-2019
Nanomedicine Market Size 2013-2019Nanomedicine Market Size 2013-2019
Nanomedicine Market Size 2013-2019Richard Smith
 
Orphan drugs market Report with Leading Competitor Analysis, Strategies and F...
Orphan drugs market Report with Leading Competitor Analysis, Strategies and F...Orphan drugs market Report with Leading Competitor Analysis, Strategies and F...
Orphan drugs market Report with Leading Competitor Analysis, Strategies and F...IMARC Group
 
Making Life Sciences a Magnet for Talent
Making Life Sciences a Magnet for TalentMaking Life Sciences a Magnet for Talent
Making Life Sciences a Magnet for TalentKelly Services
 
Enteral feeding devices market
Enteral feeding devices marketEnteral feeding devices market
Enteral feeding devices marketdanishsmith01
 
Organ Preservation Market Growth, Demand and Challenges of the Key Industry P...
Organ Preservation Market Growth, Demand and Challenges of the Key Industry P...Organ Preservation Market Growth, Demand and Challenges of the Key Industry P...
Organ Preservation Market Growth, Demand and Challenges of the Key Industry P...IMARC Group
 
Global orphan drug market outlook 2018
Global orphan drug market outlook 2018Global orphan drug market outlook 2018
Global orphan drug market outlook 2018Rajesh Sarma
 
Nutraceutical products market
Nutraceutical products marketNutraceutical products market
Nutraceutical products marketdanishsmith01
 
Pharmaceutical Industry Overview
Pharmaceutical Industry OverviewPharmaceutical Industry Overview
Pharmaceutical Industry OverviewDemetris Iacovides
 
Sample global biosimilars market
Sample global biosimilars marketSample global biosimilars market
Sample global biosimilars marketSidhantKale1
 

Similar a Emerging Biopharmaceutical Markets to Witness Exponential Growth (20)

Biosurfactants market
Biosurfactants marketBiosurfactants market
Biosurfactants market
 
Biologics market
Biologics market Biologics market
Biologics market
 
Biosimilars/Follow-on-Biologics Market
Biosimilars/Follow-on-Biologics Market Biosimilars/Follow-on-Biologics Market
Biosimilars/Follow-on-Biologics Market
 
Immuno oncology
Immuno oncologyImmuno oncology
Immuno oncology
 
M&A in pharmaceutical industry between india and italy
M&A in pharmaceutical industry between india and italyM&A in pharmaceutical industry between india and italy
M&A in pharmaceutical industry between india and italy
 
Multiple myeloma therapeutics in major developed markets to 2021 growth dri...
Multiple myeloma therapeutics in major developed markets to 2021   growth dri...Multiple myeloma therapeutics in major developed markets to 2021   growth dri...
Multiple myeloma therapeutics in major developed markets to 2021 growth dri...
 
Final
FinalFinal
Final
 
Pursuing Growth in the Age of LoE
Pursuing Growth in the Age of LoEPursuing Growth in the Age of LoE
Pursuing Growth in the Age of LoE
 
Nanomedicine Market Size 2013-2019
Nanomedicine Market Size 2013-2019Nanomedicine Market Size 2013-2019
Nanomedicine Market Size 2013-2019
 
Orphan drugs market Report with Leading Competitor Analysis, Strategies and F...
Orphan drugs market Report with Leading Competitor Analysis, Strategies and F...Orphan drugs market Report with Leading Competitor Analysis, Strategies and F...
Orphan drugs market Report with Leading Competitor Analysis, Strategies and F...
 
Biosimilars white paper asia pac 311012
Biosimilars white paper asia pac 311012Biosimilars white paper asia pac 311012
Biosimilars white paper asia pac 311012
 
Making Life Sciences a Magnet for Talent
Making Life Sciences a Magnet for TalentMaking Life Sciences a Magnet for Talent
Making Life Sciences a Magnet for Talent
 
Enteral feeding devices market
Enteral feeding devices marketEnteral feeding devices market
Enteral feeding devices market
 
Phytosterols Market .pdf
Phytosterols Market .pdfPhytosterols Market .pdf
Phytosterols Market .pdf
 
Phytosterols Market .pdf
Phytosterols Market .pdfPhytosterols Market .pdf
Phytosterols Market .pdf
 
Organ Preservation Market Growth, Demand and Challenges of the Key Industry P...
Organ Preservation Market Growth, Demand and Challenges of the Key Industry P...Organ Preservation Market Growth, Demand and Challenges of the Key Industry P...
Organ Preservation Market Growth, Demand and Challenges of the Key Industry P...
 
Global orphan drug market outlook 2018
Global orphan drug market outlook 2018Global orphan drug market outlook 2018
Global orphan drug market outlook 2018
 
Nutraceutical products market
Nutraceutical products marketNutraceutical products market
Nutraceutical products market
 
Pharmaceutical Industry Overview
Pharmaceutical Industry OverviewPharmaceutical Industry Overview
Pharmaceutical Industry Overview
 
Sample global biosimilars market
Sample global biosimilars marketSample global biosimilars market
Sample global biosimilars market
 

Más de IMARC Group

Ureteral Stents Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and O...
Ureteral Stents Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and O...Ureteral Stents Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and O...
Ureteral Stents Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and O...IMARC Group
 
Intermittent Catheters Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...
Intermittent Catheters Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...Intermittent Catheters Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...
Intermittent Catheters Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...IMARC Group
 
Insect Growth Regulators Market PPT: Growth, Outlook, Demand, Keyplayer Analy...
Insect Growth Regulators Market PPT: Growth, Outlook, Demand, Keyplayer Analy...Insect Growth Regulators Market PPT: Growth, Outlook, Demand, Keyplayer Analy...
Insect Growth Regulators Market PPT: Growth, Outlook, Demand, Keyplayer Analy...IMARC Group
 
Audio CODEC Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppor...
Audio CODEC Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppor...Audio CODEC Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppor...
Audio CODEC Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppor...IMARC Group
 
Agricultural Microbial Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...
Agricultural Microbial Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...Agricultural Microbial Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...
Agricultural Microbial Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...IMARC Group
 
Japan Railway Management System Market PPT: Growth, Outlook, Demand, Keyplaye...
Japan Railway Management System Market PPT: Growth, Outlook, Demand, Keyplaye...Japan Railway Management System Market PPT: Growth, Outlook, Demand, Keyplaye...
Japan Railway Management System Market PPT: Growth, Outlook, Demand, Keyplaye...IMARC Group
 
Japan Lateral Flow Assay Market PPT: Growth, Outlook, Demand, Keyplayer Analy...
Japan Lateral Flow Assay Market PPT: Growth, Outlook, Demand, Keyplayer Analy...Japan Lateral Flow Assay Market PPT: Growth, Outlook, Demand, Keyplayer Analy...
Japan Lateral Flow Assay Market PPT: Growth, Outlook, Demand, Keyplayer Analy...IMARC Group
 
Healthcare Extended Reality Market Growth, Demand and Challenges of the Key I...
Healthcare Extended Reality Market Growth, Demand and Challenges of the Key I...Healthcare Extended Reality Market Growth, Demand and Challenges of the Key I...
Healthcare Extended Reality Market Growth, Demand and Challenges of the Key I...IMARC Group
 
KVM Switch Market Growth, Demand and Challenges of the Key Industry Players 2...
KVM Switch Market Growth, Demand and Challenges of the Key Industry Players 2...KVM Switch Market Growth, Demand and Challenges of the Key Industry Players 2...
KVM Switch Market Growth, Demand and Challenges of the Key Industry Players 2...IMARC Group
 
DNA Methylation Market Growth, Demand and Challenges of the Key Industry Play...
DNA Methylation Market Growth, Demand and Challenges of the Key Industry Play...DNA Methylation Market Growth, Demand and Challenges of the Key Industry Play...
DNA Methylation Market Growth, Demand and Challenges of the Key Industry Play...IMARC Group
 
Polychlorotrifluoroethylene Market Growth, Demand and Challenges of the Key I...
Polychlorotrifluoroethylene Market Growth, Demand and Challenges of the Key I...Polychlorotrifluoroethylene Market Growth, Demand and Challenges of the Key I...
Polychlorotrifluoroethylene Market Growth, Demand and Challenges of the Key I...IMARC Group
 
Japan DevOps Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppo...
Japan DevOps Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppo...Japan DevOps Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppo...
Japan DevOps Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppo...IMARC Group
 
Japan Intelligent Transport Systems Market PPT: Growth, Outlook, Demand, Keyp...
Japan Intelligent Transport Systems Market PPT: Growth, Outlook, Demand, Keyp...Japan Intelligent Transport Systems Market PPT: Growth, Outlook, Demand, Keyp...
Japan Intelligent Transport Systems Market PPT: Growth, Outlook, Demand, Keyp...IMARC Group
 
Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...
Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...
Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...IMARC Group
 
Silane Market Growth, Demand and Challenges of the Key Industry Players 2024-32
Silane Market Growth, Demand and Challenges of the Key Industry Players 2024-32Silane Market Growth, Demand and Challenges of the Key Industry Players 2024-32
Silane Market Growth, Demand and Challenges of the Key Industry Players 2024-32IMARC Group
 
Marine Telematics Market Growth, Demand and Challenges of the Key Industry Pl...
Marine Telematics Market Growth, Demand and Challenges of the Key Industry Pl...Marine Telematics Market Growth, Demand and Challenges of the Key Industry Pl...
Marine Telematics Market Growth, Demand and Challenges of the Key Industry Pl...IMARC Group
 
Sexually Transmitted Disease (STD) Diagnostics Market PPT: Growth, Outlook, D...
Sexually Transmitted Disease (STD) Diagnostics Market PPT: Growth, Outlook, D...Sexually Transmitted Disease (STD) Diagnostics Market PPT: Growth, Outlook, D...
Sexually Transmitted Disease (STD) Diagnostics Market PPT: Growth, Outlook, D...IMARC Group
 
Methadone Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportu...
Methadone Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportu...Methadone Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportu...
Methadone Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportu...IMARC Group
 
Portable Solar Charger Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...
Portable Solar Charger Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...Portable Solar Charger Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...
Portable Solar Charger Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...IMARC Group
 
Warm Air Furnaces Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and...
Warm Air Furnaces Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and...Warm Air Furnaces Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and...
Warm Air Furnaces Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and...IMARC Group
 

Más de IMARC Group (20)

Ureteral Stents Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and O...
Ureteral Stents Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and O...Ureteral Stents Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and O...
Ureteral Stents Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and O...
 
Intermittent Catheters Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...
Intermittent Catheters Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...Intermittent Catheters Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...
Intermittent Catheters Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...
 
Insect Growth Regulators Market PPT: Growth, Outlook, Demand, Keyplayer Analy...
Insect Growth Regulators Market PPT: Growth, Outlook, Demand, Keyplayer Analy...Insect Growth Regulators Market PPT: Growth, Outlook, Demand, Keyplayer Analy...
Insect Growth Regulators Market PPT: Growth, Outlook, Demand, Keyplayer Analy...
 
Audio CODEC Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppor...
Audio CODEC Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppor...Audio CODEC Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppor...
Audio CODEC Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppor...
 
Agricultural Microbial Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...
Agricultural Microbial Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...Agricultural Microbial Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...
Agricultural Microbial Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...
 
Japan Railway Management System Market PPT: Growth, Outlook, Demand, Keyplaye...
Japan Railway Management System Market PPT: Growth, Outlook, Demand, Keyplaye...Japan Railway Management System Market PPT: Growth, Outlook, Demand, Keyplaye...
Japan Railway Management System Market PPT: Growth, Outlook, Demand, Keyplaye...
 
Japan Lateral Flow Assay Market PPT: Growth, Outlook, Demand, Keyplayer Analy...
Japan Lateral Flow Assay Market PPT: Growth, Outlook, Demand, Keyplayer Analy...Japan Lateral Flow Assay Market PPT: Growth, Outlook, Demand, Keyplayer Analy...
Japan Lateral Flow Assay Market PPT: Growth, Outlook, Demand, Keyplayer Analy...
 
Healthcare Extended Reality Market Growth, Demand and Challenges of the Key I...
Healthcare Extended Reality Market Growth, Demand and Challenges of the Key I...Healthcare Extended Reality Market Growth, Demand and Challenges of the Key I...
Healthcare Extended Reality Market Growth, Demand and Challenges of the Key I...
 
KVM Switch Market Growth, Demand and Challenges of the Key Industry Players 2...
KVM Switch Market Growth, Demand and Challenges of the Key Industry Players 2...KVM Switch Market Growth, Demand and Challenges of the Key Industry Players 2...
KVM Switch Market Growth, Demand and Challenges of the Key Industry Players 2...
 
DNA Methylation Market Growth, Demand and Challenges of the Key Industry Play...
DNA Methylation Market Growth, Demand and Challenges of the Key Industry Play...DNA Methylation Market Growth, Demand and Challenges of the Key Industry Play...
DNA Methylation Market Growth, Demand and Challenges of the Key Industry Play...
 
Polychlorotrifluoroethylene Market Growth, Demand and Challenges of the Key I...
Polychlorotrifluoroethylene Market Growth, Demand and Challenges of the Key I...Polychlorotrifluoroethylene Market Growth, Demand and Challenges of the Key I...
Polychlorotrifluoroethylene Market Growth, Demand and Challenges of the Key I...
 
Japan DevOps Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppo...
Japan DevOps Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppo...Japan DevOps Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppo...
Japan DevOps Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Oppo...
 
Japan Intelligent Transport Systems Market PPT: Growth, Outlook, Demand, Keyp...
Japan Intelligent Transport Systems Market PPT: Growth, Outlook, Demand, Keyp...Japan Intelligent Transport Systems Market PPT: Growth, Outlook, Demand, Keyp...
Japan Intelligent Transport Systems Market PPT: Growth, Outlook, Demand, Keyp...
 
Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...
Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...
Japan Laboratory Informatics Market PPT: Growth, Outlook, Demand, Keyplayer A...
 
Silane Market Growth, Demand and Challenges of the Key Industry Players 2024-32
Silane Market Growth, Demand and Challenges of the Key Industry Players 2024-32Silane Market Growth, Demand and Challenges of the Key Industry Players 2024-32
Silane Market Growth, Demand and Challenges of the Key Industry Players 2024-32
 
Marine Telematics Market Growth, Demand and Challenges of the Key Industry Pl...
Marine Telematics Market Growth, Demand and Challenges of the Key Industry Pl...Marine Telematics Market Growth, Demand and Challenges of the Key Industry Pl...
Marine Telematics Market Growth, Demand and Challenges of the Key Industry Pl...
 
Sexually Transmitted Disease (STD) Diagnostics Market PPT: Growth, Outlook, D...
Sexually Transmitted Disease (STD) Diagnostics Market PPT: Growth, Outlook, D...Sexually Transmitted Disease (STD) Diagnostics Market PPT: Growth, Outlook, D...
Sexually Transmitted Disease (STD) Diagnostics Market PPT: Growth, Outlook, D...
 
Methadone Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportu...
Methadone Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportu...Methadone Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportu...
Methadone Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportu...
 
Portable Solar Charger Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...
Portable Solar Charger Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...Portable Solar Charger Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...
Portable Solar Charger Market PPT: Growth, Outlook, Demand, Keyplayer Analysi...
 
Warm Air Furnaces Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and...
Warm Air Furnaces Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and...Warm Air Furnaces Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and...
Warm Air Furnaces Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and...
 

Último

To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Onlinelng ths
 
Cracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptxCracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptxWorkforce Group
 
Developing Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, OursDeveloping Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, OursKaiNexus
 
MC Heights construction company in Jhang
MC Heights construction company in JhangMC Heights construction company in Jhang
MC Heights construction company in Jhangmcgroupjeya
 
Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Lviv Startup Club
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGlokeshwarmaha
 
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...TalentView
 
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...IMARC Group
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessAPCO
 
Plano de marketing- inglês em formato ppt
Plano de marketing- inglês  em formato pptPlano de marketing- inglês  em formato ppt
Plano de marketing- inglês em formato pptElizangelaSoaresdaCo
 
Introduction to The overview of GAAP LO 1-5.pptx
Introduction to The overview of GAAP LO 1-5.pptxIntroduction to The overview of GAAP LO 1-5.pptx
Introduction to The overview of GAAP LO 1-5.pptxJemalSeid25
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access
 
Upgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsUpgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsIntellect Design Arena Ltd
 
PDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfPDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfHajeJanKamps
 
MoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor PresentationMoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor Presentationbaron83
 
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...Brian Solis
 
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBBPMedia1
 
7movierulz.uk
7movierulz.uk7movierulz.uk
7movierulz.ukaroemirsr
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examplesamberjiles31
 

Último (20)

To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Online
 
Investment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV IndustriesInvestment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV Industries
 
Cracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptxCracking the ‘Business Process Outsourcing’ Code Main.pptx
Cracking the ‘Business Process Outsourcing’ Code Main.pptx
 
Developing Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, OursDeveloping Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, Ours
 
MC Heights construction company in Jhang
MC Heights construction company in JhangMC Heights construction company in Jhang
MC Heights construction company in Jhang
 
Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
 
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
 
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
 
Plano de marketing- inglês em formato ppt
Plano de marketing- inglês  em formato pptPlano de marketing- inglês  em formato ppt
Plano de marketing- inglês em formato ppt
 
Introduction to The overview of GAAP LO 1-5.pptx
Introduction to The overview of GAAP LO 1-5.pptxIntroduction to The overview of GAAP LO 1-5.pptx
Introduction to The overview of GAAP LO 1-5.pptx
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024
 
Upgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsUpgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking Applications
 
PDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfPDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdf
 
MoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor PresentationMoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor Presentation
 
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
 
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
 
7movierulz.uk
7movierulz.uk7movierulz.uk
7movierulz.uk
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examples
 

Emerging Biopharmaceutical Markets to Witness Exponential Growth

  • 1. Emerging Biopharmaceutical Markets to Witness Exponential Growth IMARC Group, one of the world‘s leading research and advisory firms, finds that the sales of Biopharmaceuticals in Emerging markets will nearly triple its size from US$ 5.3 Billion in 2010 to US$ 13.5 Billion in 2015 IMARC Group, one of the world‘s leading research and advisory firms, finds in its new report “Global Biopharmaceutical Market Report & Forecast 2010-2015” that driven by a huge patient pool, rapid economic growth and improving intellectual property rights, the sales of biopharmaceuticals in the seven emerging markets - Russia, China, Turkey, Mexico, South Korea, India and Brazil will nearly triple from the current US$ 5.3 Billion to more than US$ 13.6 billion by 2015. As per the research findings, the treatment costs associated with biopharmaceuticals are extremely high and at times can exceed hundreds of thousands of dollars a year. Since most of the healthcare costs in the emerging markets are paid out-of-pocket, most patients cannot afford these treatments. However, the seven emerging markets taken together account for more than three billion people, representing more than 45% of the total Global population. So even if a small percentage of patients are able to afford these drugs, it still represents a huge market potential. Moreover, the GDPs of emerging markets have witnessed strong growth during the last few years, and this is likely to continue in the coming years as well. This is expected to create a huge middle class that can afford innovative treatments. The report also suggests that despite the huge opportunity, these markets will not be easy for western manufacturers to penetrate. A major challenge for manufacturers entering these markets is the fact that emerging markets are more complex and different from the developed markets as well as from each other. A strategy that will work in Turkey will not work well in India or China. Manufacturers will have to devise strategies, customized as per the requirements of the individual markets. IMARC’s new report “Global Biopharmaceutical Market Report 2010-2015” gives a deep insight into the global biopharmaceutical market. The research study serves as an analytical as well as a statistical tool to understand the strengths, weaknesses, opportunities, threats, market trends, geographical structure, therapeutic structure, competitive structure and the outlook of the global biopharmaceutical market till 2015. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists, and all those who are planning to foray into the global biopharmaceutical market in some form or the other.
  • 2. Report Highlights:  Biopharmaceuticals enjoy a higher approval success rate compared to traditional small molecule drugs. They, however, require higher investments and take longer development times.  Biopharmaceuticals are significantly more expensive than traditional medications, with the annual cost of therapy of some biopharmaceuticals touching more than a hundred thousand dollars a year. The cost of these drugs, however, is expected to be closely scrutinized by payers in the coming years.  Recombinant Proteins represented the biggest biopharmaceutical class in 2009, accounting for more than 65% of the total global biopharmaceutical sales. Growth in this class is expected to be low in most of the developed markets as a result of biosimilar entry and increasing cost containment measures.  Monoclonal Antibodies are expected to be the biggest drivers of the biopharmaceutical market in the next five years. Driven by a rich late stage pipeline and a strong uptake from both developed and emerging market, Monoclonal Antibodies are expected to be worth more than US$ 79 Billion by 2015.  Imarc expects the top eight markets (US, Germany, Japan, France, Italy, Spain, UK and Canada) to account for around 79% of the total global biopharmaceutical sales by 2015. This represents a decline of 4% over their 2009 share.  The market share of emerging markets (Brazil, Russia, India, China, Mexico, Turkey and South Korea) is likely to increase from less than 5% in 2009 to more than 8% by 2015. Countries Covered Global, US, Germany, Japan, France, Italy, Spain, United Kingdom, Canada, Russia, China, Australia, Turkey, Mexico, South Korea, India, Brazil, Argentina and Indonesia. Classes Covered for Each Region/Country Recombinant Proteins, Insulin, Erythropoietins, Interferons, Colony Stimulating Factors, Immunoglobulins, Recombinant Blood Factors, Growth Hormones, Recombinant Enzymes, Interleukins, Growth Factors, Monoclonal Antibodies and Purified Proteins. Key Features  Analysis of the key strengths, weaknesses, opportunities and threats faced by the global biopharmaceutical market.  Exhaustive in-depth individual analysis for eighteen major developed and emerging markets.  2005 to 2009 trend analysis for the global and 18 selected biopharmaceutical markets.
  • 3. 2005 to 2009 trend analysis for individual biopharmaceutical classes for the global and 18 selected biopharmaceutical markets.  2005 to 2009 trend analysis for the performance of top players for the global and 18 selected biopharmaceutical markets. Table of Contents 1. Market Definitions & Research Methodology 2. Analyst Briefing 3. Introduction to Biopharmaceuticals 4. Global Biopharmaceutical Market: Industry Analysis 4.1 Strengths 4.1.1 High Efficacy and Target Oriented Attack 4.1.2 Strong Potential to Achieve Blockbuster Status 4.1.3 Limited Generic Threat 4.1.4 Approval Success Rates are Higher than Small Molecule Drugs 4.2 Weaknesses 4.2.1 Inconvenient Drug Delivery Coupled with Short Half Lives 4.2.2 Second Line of Therapy 4.2.3 Huge Cost of Therapy 4.2.4 High Incidence of Unfavorable Side Effects 4.3 Opportunities 4.3.1 Diseases with High Unmet Needs 4.3.2 Expanding the Patient Pool by Approval into Additional Indications 4.3.3 Emerging Markets 4.3.4 Increasing New Approvals and a Strong Pipeline 4.4 Threats 4.4.1 Biopharmaceutical Drug Development is a Very Risky Venture 4.4.2 Biosimilars 4.4.3 Limited and Conditional Reimbursement 4.4.4 Uncertainties in the Economic Environment
  • 4. 5. Global Biopharmaceutical Market: Industry Performance 5.1 Market Performance & Forecast 5.1.1 Current Performance (2005-2009) 5.1.2 Market Forecasts (2010-2015) 5.2 Market Segmentation by Region 5.2.1 Current Performance (2005-2009) 5.2.2 Market Forecasts (2010-2015) 5.3 Market Segmentation by Indication 5.4 Market Segmentation by Class 5.4.1 Recombinant Proteins 5.4.2 Monoclonal Antibodies 5.4.3 Purified Proteins 5.5 Competitive Landscape 5.5.1 Top Biopharmaceutical Players 5.5.2 Top Biopharmaceutical Drugs 6. North America 6.1 US 6.1.1 Market Performance (2005-2009) 6.1.2 Market Segmentation by Class 6.1.3 Performance of Top Players 6.1.4 Market Forecasts (2010-2015) 6.2 Canada 6.2.1 Market Performance (2005-2009) 6.2.2 Market Segmentation by Class 6.2.3 Performance of Top Players 6.2.4 Market Forecasts (2010-2015) 7. Latin America 7.1 Mexico 7.1.1 Market Performance (2005-2009) 7.1.2 Market Segmentation by Class
  • 5. 7.1.3 Performance of Top Players 7.1.4 Market Forecasts (2010-2015) 7.2 Brazil 7.2.1 Market Performance (2005-2009) 7.2.2 Market Segmentation by Class 7.2.3 Performance of Top Players 7.2.4 Market Forecasts (2010-2015) 7.3 Argentina 7.3.1 Market Performance (2005-2009) 7.3.2 Market Segmentation by Class 7.3.3 Performance of Top Players 7.3.4 Market Forecasts (2010-2015) 8. Europe 8.1 Germany 8.1.1 Market Performance (2005-2009) 8.1.2 Market Segmentation by Class 8.1.3 Performance of Top Players 8.1.4 Market Forecasts (2010-2015) 8.2 France 8.2.1 Market Performance (2005-2009) 8.2.2 Market Segmentation by Class 8.2.3 Performance of Top Players 8.2.4 Market Forecasts (2010-2015) 8.3 Italy 8.3.1 Market Performance (2005-2009) 8.3.2 Market Segmentation by Class 8.3.3 Performance of Top Players 8.3.4 Market Forecasts (2010-2015) 8.4 Spain 8.4.1 Market Performance (2005-2009)
  • 6. 8.4.2 Market Segmentation by Class 8.4.3 Performance of Top Players 8.4.4 Market Forecasts (2010-2015) 8.5 UK 8.5.1 Market Performance (2005-2009) 8.5.2 Market Segmentation by Class 8.5.3 Performance of Top Players 8.5.4 Market Forecasts (2010-2015) 8.6 Russia 8.6.1 Market Performance (2005-2009) 8.6.2 Market Segmentation by Class 8.6.3 Performance of Top Players 8.6.4 Market Forecasts (2010-2015) 8.7 Turkey 8.7.1 Market Performance (2005-2009) 8.7.2 Market Segmentation by Class 8.7.3 Performance of Top Players 8.7.4 Market Forecasts (2010-2015) 9. Asia Pacific 9.1 Japan 9.1.1 Market Performance (2005-2009) 9.1.2 Market Segmentation by Class 9.1.3 Performance of Top Players 9.1.4 Market Forecasts (2010-2015) 9.2 China 9.2.1 Market Performance (2005-2009) 9.2.2 Market Segmentation by Class 9.2.3 Performance of Top Players 9.2.4 Market Forecasts (2010-2015) 9.3 Australia
  • 7. 9.3.1 Market Performance (2005-2009) 9.3.2 Market Segmentation by Class 9.3.3 Performance of Top Players 9.3.4 Market Forecasts (2010-2015) 9.4 South Korea 9.4.1 Market Performance (2005-2009) 9.4.2 Market Segmentation by Class 9.4.3 Performance of Top Players 9.4.4 Market Forecasts (2010-2015) 9.5 India 9.5.1 Market Performance (2005-2009) 9.5.2 Market Segmentation by Class11 9.5.3 Performance of Top Players 9.5.4 Market Forecasts (2010-2015) 9.6 Indonesia 9.6.1 Market Performance (2005-2009) 9.6.2 Market Segmentation by Class 9.6.3 Performance of Top Players 9.6.4 Market Forecasts (2010-2015) To buy the complete report or to get a free sample, please contact: IMARC Group Asia Email: apac@imarcgroup.com Phone: +91-120-425-6531 IMARC Group North America Email: america@imarcgroup.com Phone: +1-631-791-1145 IMARC Group Europe, Middle East & Africa Email:ema@imarcgroup.com Phone: +44-702-409-7331 To know more please visit: http://www.imarcgroup.com/global-biopharmaceutical-market-report- 2010-2015/
  • 8. Keywords Biopharmaceuticals market, Global Biopharmaceuticals market, Pharmaceuticals market, Recombinant proteins market, Monoclonal anti-bodies market, Purified Proteins market
  • 9. 2010-2015 sales forecast for the global and 18 selected biopharmaceutical markets.